During the past decade, Ospedale S. Giacomo di Castelfranco Veneto conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale S. Giacomo di Castelfranco Veneto" #1 sponsor was "Baxalta now part of Shire" with 3 trials, followed by "Fadoi Foundation, Italy" with 3 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 3 trials sponsored, "Anthos Therapeutics, Inc." with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale S. Giacomo di Castelfranco Veneto" #1 collaborator was "Itreas" with 2 trials as a collaborator, "ANìMO (National Association of Hospital Medicine Nurses)" with 1 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Mundipharma Pte Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale S. Giacomo di Castelfranco Veneto" are "Hemophilia A" (3 trials), "Deep Venous Thrombosis" (2 trials), "Prevention of Venous Thromboembolism" (2 trials), "Pulmonary Embolism" (2 trials) and "Venous Thromboembolism" (2 trials). Many other conditions were trialed in "Ospedale S. Giacomo di Castelfranco Veneto" in a lesser frequency.

Most popular intervention types in "Ospedale S. Giacomo di Castelfranco Veneto" are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abelacimab" (2 trials), "ABSORB scaffold" (1 trials), "Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802)" (1 trials), "Apixaban" (1 trials) and "Apixaban 5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale S. Giacomo di Castelfranco Veneto" are 12 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale S. Giacomo di Castelfranco Veneto". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Ospedale S. Giacomo di Castelfranco Veneto, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale S. Giacomo di Castelfranco Veneto, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".